Steris Plc
Steris Plc (STE) Covered Calls
As of September 18, 2026, STE has 19 covered call opportunities in the coming three months. Return ranges from 1.1 to 39.4% until expiration. Annualized return ranges from 16.5 to 405.3%. The nearest expiration is September 18, 2026. Maximum potential profit is $8,206.
Read more
Running STE covered calls helps you generate consistent income from Steris Plc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Steris Plc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best STE covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if STE stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling STE covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Steris Plc covered call is worth writing.
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
Income-focused investors, long-term STE holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling STE covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Steris Plc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryMedical Devices
- SectorHealthcare
- IV percentile71.83% Elevated
- Market cap (M$)19,991
- 52 weeks high-23.90%
- 52 weeks low5.07%
- Analyst recommendationBuy
1.83 - Target price$265.86
29.66% above the current stock price - Dividend—
- Payout ratio31.04%
- Earnings date2026-11-04
- P/E25.06
- Future P/E16.74
- EPS (ttm)8.18
- EPS growth next 5 years9.81%
As of September 18, 2026
| 2026-09-18 | 1 | 210.00 | 0.94 | 0.35 | 3.30 | 231.00 | 1.11 | 405.28 | -0.17 | +0.39 | 14 | 2.95 |
| 2026-12-18 | 92 | 260.00 | 24.98 | 0.35 | 2.85 | 5231.00 | 25.14 | 99.76 | -0.17 | +0.11 | 9 | 2.50 |
| 2027-03-19 | 183 | 290.00 | 39.40 | 0.10 | 1.55 | 8206.00 | 39.44 | 78.67 | -0.05 | +0.05 | 3 | 1.45 |
| 2026-10-16 | 29 | 220.00 | 5.75 | 0.85 | 2.45 | 1281.00 | 6.16 | 77.50 | -0.41 | +0.22 | 3 | 1.60 |
| 2026-11-20 | 64 | 230.00 | 10.56 | 1.00 | 4.50 | 2296.00 | 11.04 | 62.94 | -0.48 | +0.22 | 0 | 3.50 |
| 2026-12-18 | 92 | 240.00 | 15.36 | 0.55 | 3.30 | 3251.00 | 15.63 | 62.00 | -0.26 | +0.15 | 60 | 2.75 |
| 2027-03-19 | 183 | 270.00 | 29.78 | 0.05 | 2.90 | 6201.00 | 29.81 | 59.45 | -0.02 | +0.09 | 5 | 2.85 |
| 2027-03-19 | 183 | 260.00 | 24.98 | 1.00 | 3.90 | 5296.00 | 25.46 | 50.77 | -0.48 | +0.14 | 1 | 2.90 |
| 2026-12-18 | 92 | 230.00 | 10.56 | 3.70 | 4.30 | 2566.00 | 12.33 | 48.93 | -1.78 | +0.26 | 4 | 0.60 |
| 2026-11-20 | 64 | 220.00 | 5.75 | 3.80 | 7.00 | 1576.00 | 7.58 | 43.20 | -1.83 | +0.36 | 0 | 3.20 |
As of September 18, 2026
Sell covered calls with the data behind you
Find the best STE covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→